Vistos Co., Ltd
Financials
Valuation Metrics
Vistos Co., Ltd's Market Cap is ₩161B. At end of 2025 it was ₩319B. Ranked #2359 of 2,412 in KR market (top 98%), #1590 of 1,632 on KOSDAQ (top 97%), #94 of 94 in Health Care Equipment & Services (top 100%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 16.15B KRW | KR#2,359/2,412 Sec#94/94 |
| Revenue | 16.08B KRW | KR#2,196/2,412 Sec#75/94 |
| Net Income | -1.01B KRW | KR—/2,412 Sec—/94 |
| Total Assets | 29.85B KRW | KR#2,331/2,412 Sec#86/94 |
| Net Assets | 19.78B KRW | KR#2,285/2,412 Sec#86/94 |
| Employees | 69 | KR#1,883/2,412 Sec#76/94 |
| Value | ||
| P/B | 0.82x | KR#1,288/2,412 Sec#30/94 |
| P/S | 1.00x | KR#1,405/2,412 Sec#23/94 |
| FCF Yield | -13.67% | KR—/2,412 Sec—/94 |
| Profitability | ||
| ROE | -5.10% | KR#1,801/2,412 Sec#61/94 |
| ROA | -3.38% | KR#1,853/2,412 Sec#62/94 |
| Op. Margin | -11.02% | KR#2,007/2,412 Sec#64/94 |
| Revenue Growth | -12.01% | KR#1,967/2,412 Sec#81/94 |
| Financial Health | ||
| Debt Ratio | 50.95% | KR#973/2,412 Sec#55/94 |
| Total Debt | 4.70B KRW | KR#1,798/2,412 Sec#65/94 |
| FCF | -2.21B KRW | KR#1,350/2,412 Sec#42/94 |
| Cash | 8.27B KRW | KR#1,794/2,412 Sec#59/94 |
| Current Ratio | 2.56x | KR#669/2,412 Sec#39/94 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,412 Sec—/94 |
| Performance | ||
| 1Y Return | -68.29% | KR#2,237/2,412 Sec#88/94 |
| 1M Return | -6.07% | KR#1,900/2,412 Sec#85/94 |
| From 52W High | -76.43% | KR#2,265/2,412 Sec#90/94 |
| 1Y MDD | -78.67% | KR#2,260/2,412 Sec#88/94 |
| Trading | ||
| Volume | 23,261 shares | KR#1,838/2,412 Sec#77/94 |
| Trading Value | 62.5M KRW | KR#1,999/2,412 Sec#81/94 |
| Foreign Own. | 0.00% | KR—/2,412 Sec—/94 |
| Per Share | ||
| EPS | -169 KRW | KR—/2,412 Sec—/94 |
| BPS | 3,319 KRW | KR#1,799/2,412 Sec#51/94 |
Company Info
Bistos, established in 2001, specializes in manufacturing medical devices, particularly for fetal and neonatal care, including fetal monitors, jaundice therapy devices, and incubators, and was listed on KOSDAQ in 2022. Over 90% of its sales come from exports to over 120 countries. The company is expanding into home medical devices like breast pumps and thermometers, patient monitors, and aims to become a leader in biosignal technology by exploring ADHD/dementia treatment and wearable healthcare. Bistos is headquartered in Gyeonggi-do, Seongnam-si.